12
Mar
2015
Antibiotic R&D Is Getting More Attention. Who’s Doing What?
This content is available for subscribers of the Timmerman Report.
Sign in to your account.This content is available for subscribers of the Timmerman Report.
Sign in to your account.The Timmerman Report Gives You Consistent In-Depth Reporting on Biotechnology. Get Your Edge.
Already have an account?
Please sign in to your account.
I am available to speak about biotech trends at public and private biotech events. See me for details.